Extracellular DNA: A bridge to cancer

Cancer Research

Volumn 75, Issue 20, 2015, Pages 4260-4264

  Hawes, Martha C ^a   Wen, Fushi ^b   Elquza, Emad ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; DNA; DEOXYRIBONUCLEASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CIRCULATING TUMOR CELL; DNA DETERMINATION; EHRLICH ASCITES TUMOR; EXTRACELLULAR TRAP; HUMAN; LEWIS CARCINOMA; LIVER METASTASIS; LYMPHATIC LEUKEMIA; METASTASIS; METASTASIS POTENTIAL; NECROSIS; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; TUMOR CELL DESTRUCTION; UNSPECIFIED SIDE EFFECT; CASE CONTROL STUDY; EXTRACELLULAR SPACE; GENETICS; METABOLISM; NEOPLASMS;

CASE-CONTROL STUDIES; DEOXYRIBONUCLEASE I; DEOXYRIBONUCLEASES; DNA; EXTRACELLULAR SPACE; EXTRACELLULAR TRAPS; HUMANS; NEOPLASMS;

EID: 84947092964     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-1546     Document Type: Review

References (58)

1. Kaplan MJ, Radic M. NETs: double-edged swords of innate immunity. J Immunol 2012;189:2689-95.
2. Rosner K, Kasprzak MF, Horenstein A C J, Thurston HL, Abrams J, Kerwin LY, et al. Engineering a waste management enzyme to overcome cancer resistance to apoptosis: adding DNase1 to the anti-cancer toolbox. Cancer Gene Ther 2011;18:346-57.
3. Hawes MC, Curlango-Rivera G, Wen F, White GJ, Van Etten HD, Xiong Z. Extracellular DNA: the tip of root defenses? Plant Sci 2011;180:741-5.
4. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science 2004;303:1532-5.
5. Brinkmann V, Zychlinsky A. NETs: is immunity the second function of chromatin? J Cell Biol 2012;198:773-83.
6. Halverson T W R, Wilton M, Poon K K H, Petri B, Lewenza S. DNA is an antimicrobial component of neutrophil extracellular traps. PLoS Pathog 2015;11:e1004593.
7. Nasser W, Beres SB, Olsen RJ, Dean MA, Rice KA, Long SW, et al. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derivedfrom3, 615genome sequences. ProcNatl Acad Sci 2014;111:E1768-76.
8. Wen F, White GJ, Van Etten HD, Xiong Z, Hawes MC. Extracellular DNA is required for root tip resistance to fungal infection. Plant Physiol 2009;151:820-9.
9. Wen F, Van Etten HD, Tsaprailis G, Hawes MC. Extracellular proteinsinpea root tip and border cell exudates. Plant Physiol 2007;143:773-83.
10. Bardoel BW, Kenny EF, Sollberger G, Zychlinsky A. The balancing act of neutrophils. Cell Host Microbe 2014;15:526-36.
11. Metzler KD, Goosmann C, Lubojemska A, Zychlinsky A, Papayanopoulos V. A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Rep 2014;8:883-96.
12. Kolaczkowska E, Jenne CN, Surewaard B G J, Thanabalasuriar A, Lee W, Sanz M, et al. Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature. Nat Commun 2015;6:1-13.
13. Fattahi F, Grailer JJ, Jajou L, Zetoune FS, Andjelkovic AV, Ward PA. Organ distribution of histones after intravenous infusion of FITC histones or after sepsis. Immunol Res 2015;61:177-86.
14. Cools-Lartigue J, Spicer J, Najmeh S, Ferri L. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest 2014;123:3446-58.
15. Cooper PR, Palmer LJ, Chapple I L C. NETs as a new paradigm in innate immunity: friend or foe? Periodontol 2013;63:165-97.
16. Demers M, Wagner DD. NETs: a new link to cancer-associated thrombosis and potential implications for tumor progression. OncoImmunol 2013;2:322946.
17. Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA, et al. Cancers predispose neutrophilsto release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci 2012;109:13076-81.
18. Hakkin A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al. Impairment of NET degradation is associated with lupus nephritis. Proc Natl Acad Sci 2010;107:9813-8.
19. Mangold A, Alias S, Scherz T, Hofbauer T, Jakowitsch J, Panzenbock A, et al. Coronary NET burden and DNase activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ Res 2015;116:1182-92.
20. Spicer JD, McDonald B, Cools-Lartigue JJ, Chow SC, Giannias B, Kubes P, et al. Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells. Cancer Res 2012;72:3919-27.
21. Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001;28:313-4.
22. Al-Mayouf SM, SunkerA, Abdwani R, Al Abrawi S, Almurshedi F, Alhashmi N, et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 2011;43:1186-8.
23. Lazarus RA, WagenerJS. Recombinant human deoxyribonuclease I. Pharm Biotechnol 4th Edition 2013;321-36.
24. Jimenez-Alcazar M, Napirei M, Panda R, Kohler EC, Kremer-Hovinga A, Mannherz HG, et al. Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies. J Thromb Haemost 2015;5:732-42.
25. Leon SA, Shapiro B, Sklaroff DM, Yarol MJ. Free DNAinthe serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646-50.
26. Dewez B, Lans M, Allaeys V, Karaoglou A, Taper H, Roberfroid M. SADA, a sensitive marker for the therapeutic monitoring of cancer patients-methodological aspects. Eur J Clin Chem Clin Biochem 1993;31:793-7.
27. Patel PS, Patel BP, Rawal RM, Raval GN, Patel MM, Patel JB, et al. Evaluation of serum alkaline DNase activity in treatment monitoring of head and neck cancer patients. Tumor Biol 2000;21:82-9.
28. Tamkovich S, Cherepanova AV, Kolesnikova EV, Rykova EY, Pyshnyi DV, Vlassov VV, et al. Circulating DNA and DNase activity in human blood. Ann NY Acad Sci 2006;1075:191-6.
29. Cherepanova AV, Tamkovich SN, Bryzgunova OE, Vlassov VV, Laktionov PP. Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors. Ann NY Acad Sci 2008;1137:218-21.
30. Trejo-Becerril C, Perez-Cardenas E, Taja-Chayeb L, Anker P, Herrera-Goepfert R, Medina-Velazquez LA, et al. Cancer progression mediated by horizontal gene transfer in an in vivo model. PLos One 2012;7:e52754.
31. Oklu R, Albadawi H, Tanabe K, Manatis-Lornell AJ, Watkins MT. Cancer associated extracellular DNA traps in human plasma may predispose to venous thrombosis. J Vasc Interv Radiol 2013;24:S51.
32. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer-a survey. Biochim Biophys Acta 2007;1775:181-232.
33. Singh N, Gupta S, Pandey RM, Chauhan SS, Saraya A. High levels of cellfree circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis, and poor survival. Cancer Invest 2015;33:78-85.
34. Alcazar-Leyva S, Ceron E, Masso F, Montano LF, Gorocica P, Alvarado-Vasquez N. Incubation with DNase I inhibits tumor cell proliferation. Med Sci Monit 2009;15:CR51-5.
35. de Lamirande G. Action of deoxyribonuclease and ribonuclease on the growth of Ehrlich ascites carcinoma in mice. Nature 1961;192:52-4.
36. Salganik RI, Mart'ynova RP, Matieneo NA, Ronichevskaya GM. Effect of deoxyribonuclease on the course of lymphatic leukaemia in AKR mice. Nature 1967;214:100-2.
37. Sugihara S, Yamamoto T, Tanaka H, Kambara T, Hiraoka T, Miyauchi Y. Deoxyribonuclease treatment prevents blood-borne liver metastasis of cutaneously transplanted tumour cells in mice. Brit J Cancer 1993;67:66-70.
38. Shklyaeva OA, Mironova NL, Malkova EM, Taranov OS, Ryabchikova EI, Zenkova MA, et al. Cancer-suppressive effect of RNase A and DNase I. Biochem Biophys Mol Biol 2008;420:108-11.
39. Patutina O, Mironova N, Ryabhikova E, Popova N, Nikolin V, Kaledin V, et al. Inhibition of metastasis development by daily administration of ultralow doses of RNase A and DNase I. Biochimie 2011;93:689-96.
40. Wen F, Shen A, Choi A, Gerner EW, Shi J. Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis. Cancer Res 2013;73:4256-66.
41. Garcia-Olmo DC, Dominguez C, Garcia-Arranz M, Anker P, Stroun M, Garcia-Verdugo JM, et al. Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res 2010;70:560-7.
42. van der Vaart M, Pretorius PJ. The originof circulating free DNA. Clin Chem 2007;53:2215.
43. Cabral R E S, Neto J B C, Carvalho M G C. Circulating DNA as a biomarker for early detection of cancer: a brief update with an emphasis on lung cancer. Open Lung Cancer J 2010;3:38-44.
44. Gahan PB. Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer. EPMA J 2010;1:503-12.
45. Jin D, Xie S, Mo Z, Liang Y, Guo B, Huang G, et al. Circulating DNA: important biomarker of cancer. J Mol Biomarkers Diagn 2012; S2:009.
46. Sueoka-Aragane N, Sato A, Kobayashi N, Ide M, Yokoo M, Nagano Y, et al. Correlation between plasma DNA and tumor status in an animal model. PLOS One 2014;9:e111881.
47. Piciocchi M, Cardin R, Vitale A, Vanin V, Giacomin A, Pozzan C, et al. Circulating free DNA in the progression of liver damage to hepatocellular carcinoma. Hepatol Int 2013;7:1050-7.
48. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids-a promising, non-invasive tool for early detection of several human diseases. FEBS Lett 2007;581:795-9.
49. Ziegler A, Zangemeister-Wittke U, Stahel RA. Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 2002;28:255-71.
50. Sozzi G, Conte D, Leon M, Cirincione R, Roz L, Ratcliffe C, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21:3902-8.
51. Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 2011;71:2411-6.
52. Wroblewski F, Bodansky O. Presence of desoxyribonuclease activity in human serum. Proc Soc Exptl Biol Med 1950;74:443-5.
53. Saffarzadeh M, Preissner KT. Fighting against the dark side of NETs in disease: manoeuvres for host protection. Curr Opin Hematol 2013;20:3-9.
54. Tabaries S, Ouellet V, Hsu BE, Annis MG, Rose A A N, Meunier L, et al. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Breast Cancer Res 2015;17:45-63.
55. Glinsky VG, Glinsky GV, Glinskii OV, Husley VH, Turk JR, Mossine VV, et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 2003;63:3805-11.
56. Leipner J, Saller R. Systemic enzyme therapy in oncology. Drugs 2000;59:769-80.
57. Curlango-Rivera C, Flores-Lara Y, Cho I, Huskey DA, Xiong Z, Hawes MC. Signals controlling extracellular trap formation in plant and animal immune responses. Clin Microbiol 2014;3:5-7.
58. Velders M, Treff G, Maqchus K, Bosnyak E, Steinacker J, Schumann U. Exercise is a potent stimulus for enhancing circulating DNase activity. Clin Biochem 2014;47:471-4.